TY - JOUR
T1 - Meeting commentary-"Parkinson's disease
T2 - From patient to product"
AU - Wahlich, John
AU - Elder, David
AU - Liu, Fang
AU - Hughes, Carmel
AU - Orlu-Gul, Mine
N1 - John Wahlich, et al, 'Meeting commentary–“Parkinson’s disease: From patient to product”', International Journal of Pharmaceutics, Vol. 494 (1): 167-171, October 2015, doi: https://doi.org/10.1016/j.ijpharm.2015.07.074.
PY - 2015/10/15
Y1 - 2015/10/15
N2 - A meeting organised by the Academy of Pharmaceutical Sciences (APSGB) Age-Related Medicines Focus Group took place on the 19th of May 2015, in GlaxoSmithKline Ware, UK [∗]. The meeting was the first of a planned series of disease specific meetings organised by APSGB. It was attended by a number of experts involved with the treatment and development of drugs for the older adult, including clinicians, pharmacists, academics, regulators and representatives from industry. The event created the platform to discuss the provision of medicines for the treatment of Parkinson's disease (PD) from a pharmaceutical sciences perspective. 'Medications are something you prescribe: something that gives me my life back' (A PD sufferer).
AB - A meeting organised by the Academy of Pharmaceutical Sciences (APSGB) Age-Related Medicines Focus Group took place on the 19th of May 2015, in GlaxoSmithKline Ware, UK [∗]. The meeting was the first of a planned series of disease specific meetings organised by APSGB. It was attended by a number of experts involved with the treatment and development of drugs for the older adult, including clinicians, pharmacists, academics, regulators and representatives from industry. The event created the platform to discuss the provision of medicines for the treatment of Parkinson's disease (PD) from a pharmaceutical sciences perspective. 'Medications are something you prescribe: something that gives me my life back' (A PD sufferer).
KW - Dosage form
KW - Formulation
KW - Medicine
KW - Older adult
KW - Parkinson's disease
UR - http://www.scopus.com/inward/record.url?scp=84939824795&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2015.07.074
DO - 10.1016/j.ijpharm.2015.07.074
M3 - Article
AN - SCOPUS:84939824795
SN - 0378-5173
VL - 494
SP - 167
EP - 171
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
IS - 1
M1 - 15078
ER -